Xiao Hui Ji
Direktor/Vorstandsmitglied bei LEGEND BIOTECH CORPORATION
Vermögen: 409 264 $ am 30.04.2024
Profil
Xiao Hui Ji is the Chairman & Chief Executive Officer of Elpiscience Biopharma Ltd., a company he founded in 2017.
He is also currently serving as an Independent Director at Legend Biotech Corp.
since 2020.
Previously, Dr. Ji held the position of Chief Executive Officer at PharmaLegacy Laboratories (Shanghai) Co., Ltd.
He was also a Director at The BayHelix Group from 2008 to 2013 and Vice President-Business Development at Roche Holding AG from 2013 to 2016.
From 2017 to 2020, he worked as a Partner at LAV Management Co., Ltd.
In terms of education, Dr. Ji holds an MBA from The University of Chicago and has completed graduate studies at The University of Sheffield and China Medical University.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
LEGEND BIOTECH CORP.
0,01% | 31.12.2023 | 18 427 ( 0,01% ) | 409 264 $ | 30.04.2024 |
Aktive Positionen von Xiao Hui Ji
| Unternehmen | Position | Beginn |
|---|---|---|
| LEGEND BIOTECH CORPORATION | Direktor/Vorstandsmitglied | 01.05.2020 |
Elpiscience Biopharma Ltd.
 Elpiscience Biopharma Ltd. Pharmaceuticals: MajorHealth Technology Elpiscience Biopharma Ltd. engages in the development of cutting-edge immunotherapies to fight cancer. Its business scope includes technology research and development, transfer of own technology achievements and provision of related technical advice and technical services of biomedicine and biotechnology; import and export, and wholesale of mechanical equipment, electronic products, instrumentation, and plastic products. The company was founded on September 30, 2017 and is headquartered in Shanghai, China. | Vorstandsvorsitzender | 01.01.2017 |
Ehemalige bekannte Positionen von Xiao Hui Ji
| Unternehmen | Position | Ende |
|---|---|---|
LAV Management Co., Ltd.
 LAV Management Co., Ltd. Investment ManagersFinance LAV Management Co., Ltd. (LAV) is a venture capital subsidiary of Eli Lilly & Co. founded in 2008. The firm is headquartered in Shanghai, China with branches located in Central, Hong Kong and California, United States. | Corporate Officer/Principal | 01.05.2020 |
| ROCHE HOLDING AG | Corporate Officer/Principal | 01.12.2016 |
| The BayHelix Group | Direktor/Vorstandsmitglied | 01.01.2013 |
PharmaLegacy Laboratories (Shanghai) Co., Ltd.
 PharmaLegacy Laboratories (Shanghai) Co., Ltd. Miscellaneous Commercial ServicesCommercial Services PharmaLegacy Laboratories (Shanghai) Co., Ltd. engages in the provision of pharmacodynamics, pharmacokinetics, non-GLP toxicology, in vitro immunology, and three types of medical device evaluation services in line with international standards. It provides drug research & development preclinical research services such as pharmacodynamic research evaluation and pharmacokinetic research evaluation; device research & development preclinical research services such as preclinical effectiveness and safety evaluation of innovative medical devices; and experimental mice. The company was founded on March 7, 2008 and is headquartered in Shanghai, China. | Vorstandsvorsitzender | 01.01.2012 |
Ausbildung von Xiao Hui Ji
| The University of Chicago | Masters Business Admin |
| The University of Sheffield | Graduate Degree |
| China Medical University | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| ROCHE HOLDING AG | Health Technology |
| LEGEND BIOTECH CORPORATION | Health Technology |
| Private Unternehmen | 4 |
|---|---|
LAV Management Co., Ltd.
LAV Management Co., Ltd. Investment ManagersFinance LAV Management Co., Ltd. (LAV) is a venture capital subsidiary of Eli Lilly & Co. founded in 2008. The firm is headquartered in Shanghai, China with branches located in Central, Hong Kong and California, United States. | Finance |
| The BayHelix Group | |
Elpiscience Biopharma Ltd.
Elpiscience Biopharma Ltd. Pharmaceuticals: MajorHealth Technology Elpiscience Biopharma Ltd. engages in the development of cutting-edge immunotherapies to fight cancer. Its business scope includes technology research and development, transfer of own technology achievements and provision of related technical advice and technical services of biomedicine and biotechnology; import and export, and wholesale of mechanical equipment, electronic products, instrumentation, and plastic products. The company was founded on September 30, 2017 and is headquartered in Shanghai, China. | Health Technology |
PharmaLegacy Laboratories (Shanghai) Co., Ltd.
PharmaLegacy Laboratories (Shanghai) Co., Ltd. Miscellaneous Commercial ServicesCommercial Services PharmaLegacy Laboratories (Shanghai) Co., Ltd. engages in the provision of pharmacodynamics, pharmacokinetics, non-GLP toxicology, in vitro immunology, and three types of medical device evaluation services in line with international standards. It provides drug research & development preclinical research services such as pharmacodynamic research evaluation and pharmacokinetic research evaluation; device research & development preclinical research services such as preclinical effectiveness and safety evaluation of innovative medical devices; and experimental mice. The company was founded on March 7, 2008 and is headquartered in Shanghai, China. | Commercial Services |
